Cite
Data from First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
MLA
James L. Gulley, et al. Data from First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....78f97adb9235f571b3d41336e40689cd&authtype=sso&custid=ns315887.
APA
James L. Gulley, Jeffrey Schlom, Elisa Bertotti, Matthew R. Silver, Marijo Bilusic, Ravi A. Madan, Jennifer L. Marté, Elizabeth Lamping, Sheri McMahon, Agnes S. Montgomery, Renee N. Donahue, Caroline Jochems, Joseph W. Kim, Christopher R. Heery, & Julius Strauss. (2023). Data from First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors.
Chicago
James L. Gulley, Jeffrey Schlom, Elisa Bertotti, Matthew R. Silver, Marijo Bilusic, Ravi A. Madan, Jennifer L. Marté, et al. 2023. “Data from First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....78f97adb9235f571b3d41336e40689cd&authtype=sso&custid=ns315887.